Radiation-induced impairment in lung lymphatic vasculature.
Ye Cui, Julie Wilder, Cecilia Rietz...
https://pubmed.ncbi.nlm.nih.gov/25412238/Actively Recruiting
Led by Fatebenefratelli Hospital · Updated on 2021-10-26
10000
Participants Needed
1
Research Sites
417 weeks
Total Duration
Researchers are investigating a new approach to heart stress imaging called the ABCDE protocol, developed from the previous SE 2020 study. This international, multicenter study focuses on various heart conditions including coronary artery disease, heart failure with preserved ejection fraction, hypertrophic cardiomyopathy, valvular heart disease, and complications after chest radiotherapy, chemotherapy, or COVID-19. The study aims to enroll over 10,000 patients from multiple countries and labs, following them for at least five years to improve stress echocardiography as a versatile diagnostic tool. The study uses different types of stress echocardiography, including physical, pharmacologic, and pacing stress tests, with a standardized ABCDE protocol to assess heart function. Participating labs will use AI software and ultrasound enhancing agents to support uniform testing and data collection. The study also includes specialized projects targeting specific conditions such as repaired Tetralogy of Fallot, heart donors, and coronary vasospasm, all integrated under the ABCDE-SE platform. Participants will undergo regular clinical follow-ups with detailed data collection on demographics, lifestyle, imaging, and cardiovascular events. The study measures important outcomes like all-cause death, cardiac death, and cancer diagnosis over five years. Data on environmental factors and medical radiation exposure will also be analyzed. This approach aims to provide strong evidence for the use of stress echocardiography as a low-cost, radiation-free, and accessible test for patients worldwide.
CONDITIONS
Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Q
Quirino Ciampi, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fatebenefratelli Hospital
Lead Sponsor
National Research Council, Institute of Clinical Physiology, Italy
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day procedure
Participants undergo the ABCDE-Stress Echo test using physical, pharmacologic, or pacing stress according to guidelines to assess heart function and identify various heart conditions following a standardized protocol.
1 visit (in-person)
Duration - Up to 5 years
Participants are observed over several years to monitor cardiovascular and non-cardiovascular health outcomes, including mortality and disease diagnoses, following their initial diagnostic evaluation.
Periodic follow-up visits during the monitoring period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
12
Have more questions? Get in touch with our team for quick support
Ye Cui, Julie Wilder, Cecilia Rietz...
https://pubmed.ncbi.nlm.nih.gov/25412238/Lauro Cortigiani, Clara Carpeggiani, Patrizia Landi...
https://pubmed.ncbi.nlm.nih.gov/31324358/Milind Y Desai, Stephan Windecker, Patrizio Lancellotti...
https://pubmed.ncbi.nlm.nih.gov/31416535/Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer...
https://pubmed.ncbi.nlm.nih.gov/32133741/Angela Zagatina, Nadezhda Zhuravskaya, Dmitry Shmatov...
https://pubmed.ncbi.nlm.nih.gov/32036487/Tonino Bombardini, Davide Pacini, Luciano Potena...
https://pubmed.ncbi.nlm.nih.gov/32100982/William A Zoghbi, Marcelo F DiCarli, Ron Blankstein...
https://pubmed.ncbi.nlm.nih.gov/32646721/Sarah C Darby, Marianne Ewertz, Paul McGale...
https://pubmed.ncbi.nlm.nih.gov/23484825/Quirino Ciampi, Angela Zagatina, Lauro Cortigiani...
https://pubmed.ncbi.nlm.nih.gov/31672185/Eugenio Picano, Quirino Ciampi, Rodolfo Citro...
https://pubmed.ncbi.nlm.nih.gov/28100277/Fatebenefratelli Hospital
Lead Sponsor
National Research Council, Institute of Clinical Physiology, Italy
Collaborating Sponsor